Which feature best distinguishes Type A (Augmented) adverse drug reactions from Type B (Bizarre) adverse drug reactions?

Explanation

## Type A vs Type B Adverse Drug Reactions **Key Point:** Type A and Type B reactions represent fundamentally different mechanisms and predictability patterns — understanding this distinction is essential for pharmacovigilance and clinical management. ### Comparison Table | Feature | Type A (Augmented) | Type B (Bizarre) | |---------|-------------------|------------------| | **Dose-dependence** | Yes, dose-related | No, not dose-related | | **Predictability** | Predictable from pharmacology | Unpredictable, idiosyncratic | | **Incidence** | Common (10–20% of ADRs) | Rare (1–6% of ADRs) | | **Mechanism** | Exaggeration of known pharmacologic effect | Unrelated to known drug action | | **Genetic factors** | Minimal | Often genetic predisposition | | **Examples** | Bleeding with warfarin overdose, hypoglycemia with excess insulin | Aplastic anemia with chloramphenicol, Stevens-Johnson syndrome with sulfonamides | | **Management** | Dose reduction or withdrawal | Immediate withdrawal; rechallenge contraindicated | **High-Yield:** Type A reactions account for ~80% of all ADRs and are largely preventable through dose adjustment, whereas Type B reactions are rare, unpredictable, and require permanent drug avoidance once identified. **Clinical Pearl:** A patient on warfarin presenting with an INR of 12 and bleeding (Type A) can be managed with dose reduction and vitamin K; however, a patient developing aplastic anemia on chloramphenicol (Type B) must discontinue the drug permanently — rechallenge is contraindicated. **Mnemonic:** **Type A = Augmented, Anticipated, Avoidable** (by dose adjustment); **Type B = Bizarre, unpredictable, requires permanent avoidance**. ### Why Dose-Dependence Is the Best Discriminator Type A reactions are **dose-dependent and predictable** because they represent an exaggeration of the drug's known pharmacologic effect. For example: - Warfarin → bleeding (dose-related) - ACE inhibitor → hypotension (dose-related) - Metformin → lactic acidosis (dose-related) Type B reactions are **NOT dose-dependent** and occur in genetically susceptible individuals at any dose. Examples: - Chloramphenicol-induced aplastic anemia (can occur at therapeutic doses) - Penicillin anaphylaxis (IgE-mediated, independent of dose) - Carbamazepine-induced Stevens-Johnson syndrome (HLA-B*1502 association) This distinction directly impacts clinical management: Type A reactions can often be managed by dose reduction; Type B reactions require permanent withdrawal.